The Early Treatment for Retinopathy of Prematurity Study (ETROP)

Clinical Trial ID NCT00027222

PubWeight™ 18.88‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00027222

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011 7.37
2 Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010 5.23
3 Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2010 1.64
4 Visual field extent at 6 years of age in children who had high-risk prethreshold retinopathy of prematurity. Arch Ophthalmol 2011 0.87
5 Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS 2011 0.86
6 Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity. Arch Ophthalmol 2012 0.84
7 Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity. Ophthalmology 2013 0.79
8 β-Blocking and racial variation in the severity of retinopathy of prematurity. Arch Ophthalmol 2012 0.79
9 Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol 2010 0.77
10 Grating visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2011 0.76
Next 100